Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (329)
HARROW, INC. (HROW)
BOLL ANDREW R. — PRESIDENT AND CFO
Shares
3,500
Price
$29.90
Total Value
$104.65K
Shares Held After
814,679
% of Holdings
0.4%
HARROW, INC. (HROW)
BAUM MARK L — Director
Shares
10,000
Price
$30.20
Total Value
$302.00K
Shares Held After
2,996,130
% of Holdings
0.3%
ORASURE TECHNOLOGIES INC (OSUR)
Boyd Steven Kyle — Director
Shares
25,000
Price
$2.99
Total Value
$74.75K
Shares Held After
113,462
% of Holdings
22.0%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
180
Price
$147.80
Total Value
$26.60K
Shares Held After
3,500,048
% of Holdings
0.0%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
13,776
Price
$146.96
Total Value
$2.02M
Shares Held After
3,500,228
% of Holdings
0.4%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
25,352
Price
$146.15
Total Value
$3.71M
Shares Held After
3,514,004
% of Holdings
0.7%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
52,776
Price
$144.80
Total Value
$7.64M
Shares Held After
3,539,356
% of Holdings
1.5%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
12,309
Price
$144.13
Total Value
$1.77M
Shares Held After
3,592,132
% of Holdings
0.3%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
17,717
Price
$12.86
Total Value
$227.84K
Shares Held After
195,178
% of Holdings
8.3%
TREACE MEDICAL CONCEPTS, INC. (TMCI)
Treace John T. — Director
Shares
61,750
Price
$2.62
Total Value
$161.49K
Shares Held After
7,158,313
% of Holdings
0.9%
MYRIAD GENETICS INC (MYGN)
Bisaro Paul — Director
Shares
7,500
Price
$3.69
Total Value
$27.64K
Shares Held After
97,441
% of Holdings
7.7%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$77.92
Total Value
$584.40K
Shares Held After
400,330
% of Holdings
1.8%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
1,575
Price
$223.50
Total Value
$352.01K
Shares Held After
41,786
% of Holdings
3.6%
ORASURE TECHNOLOGIES INC (OSUR)
Boyd Steven Kyle — Director
Shares
25,000
Price
$3.02
Total Value
$75.50K
Shares Held After
88,462
% of Holdings
28.3%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
5,310
Price
$148.14
Total Value
$786.62K
Shares Held After
3,604,441
% of Holdings
0.1%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
6,524
Price
$147.50
Total Value
$962.29K
Shares Held After
3,609,751
% of Holdings
0.2%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
53,610
Price
$145.94
Total Value
$7.82M
Shares Held After
3,616,275
% of Holdings
1.5%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
159,623
Price
$145.26
Total Value
$23.19M
Shares Held After
3,669,885
% of Holdings
4.2%
TREACE MEDICAL CONCEPTS, INC. (TMCI)
Treace John T. — Director
Shares
49,013
Price
$2.46
Total Value
$120.53K
Shares Held After
7,096,563
% of Holdings
0.7%
JOINT Corp (JYNT)
JOBSON CHARLES E — 10% Owner
Shares
20,375
Price
$8.57
Total Value
$174.61K
Shares Held After
1,793,854
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$583.81
Total Value
$210.17K
Shares Held After
40,513
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$582.32
Total Value
$46.59K
Shares Held After
40,873
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
371
Price
$581.52
Total Value
$215.74K
Shares Held After
40,953
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,494
Price
$580.50
Total Value
$867.27K
Shares Held After
41,324
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,752
Price
$579.58
Total Value
$1.02M
Shares Held After
42,818
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,874
Price
$578.63
Total Value
$1.08M
Shares Held After
44,570
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,567
Price
$577.58
Total Value
$905.07K
Shares Held After
46,444
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
624
Price
$576.34
Total Value
$359.64K
Shares Held After
48,011
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,378
Price
$575.40
Total Value
$792.90K
Shares Held After
48,635
% of Holdings
2.8%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
1,937
Price
$66.87
Total Value
$129.53K
Shares Held After
488,437
% of Holdings
0.4%
Dyne Therapeutics, Inc. (DYN)
Kerr Douglas — Chief Medical Officer
Shares
1,564
Price
$18.36
Total Value
$28.72K
Shares Held After
170,042
% of Holdings
0.9%
Dyne Therapeutics, Inc. (DYN)
Lucera Erick — Chief Financial Officer
Shares
1,448
Price
$18.36
Total Value
$26.59K
Shares Held After
123,925
% of Holdings
1.2%
Dyne Therapeutics, Inc. (DYN)
Cox John — Director
Shares
3,311
Price
$18.36
Total Value
$60.79K
Shares Held After
370,834
% of Holdings
0.9%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
4,000
Price
$4.54
Total Value
$18.17K
Shares Held After
626,888
% of Holdings
0.6%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Militello John — Vice President of Finance, Treasurer, Principal Accounting Officer
Shares
855
Price
$3.61
Total Value
$3.08K
Shares Held After
90,164
% of Holdings
0.9%
Pediatrix Medical Group, Inc. (MD)
Weis Shirley A — Director
Shares
36,028
Price
$23.75
Total Value
$855.66K
Shares Held After
0
% of Holdings
100.0%
Dyne Therapeutics, Inc. (DYN)
Friedl-Naderer Johanna — Chief Commercial Officer
Shares
228
Price
$18.36
Total Value
$4.19K
Shares Held After
154,353
% of Holdings
0.1%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Shah Gaurav — CEO
Shares
2,728
Price
$3.61
Total Value
$9.84K
Shares Held After
1,043,327
% of Holdings
0.3%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Wilson Martin — General Counsel
Shares
3,361
Price
$3.61
Total Value
$12.12K
Shares Held After
678,639
% of Holdings
0.5%
CEL SCI CORP (CVM)
KERSTEN GEERT R — Director
Shares
100,000
Price
$1.19
Total Value
$119.00K
Shares Held After
222,497
% of Holdings
44.9%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
14,056
Price
$28.58
Total Value
$401.79K
Shares Held After
63,443
% of Holdings
18.1%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Priest Brady Patrick — CEO of Clover Care Services
Shares
98,039
Price
$3.52
Total Value
$345.10K
Shares Held After
2,040,222
% of Holdings
4.6%
ANI PHARMACEUTICALS INC (ANIP)
Walsh Patrick D — Director
Shares
10,000
Price
$80.63
Total Value
$806.30K
Shares Held After
38,432
% of Holdings
20.6%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
600
Price
$70.81
Total Value
$42.49K
Shares Held After
767,780
% of Holdings
0.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
3,950
Price
$69.79
Total Value
$275.66K
Shares Held After
768,380
% of Holdings
0.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
3,350
Price
$68.88
Total Value
$230.75K
Shares Held After
772,330
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
2,100
Price
$68.10
Total Value
$143.01K
Shares Held After
775,680
% of Holdings
0.3%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
44,679
Price
$0.54
Total Value
$24.13K
Shares Held After
1,126,496
% of Holdings
3.8%
Absci Corp (ABSI)
Pangalos Menelas N — Director
Shares
37,453
Price
$5.36
Total Value
$200.75K
Shares Held After
232,308
% of Holdings
16.1%
ANI PHARMACEUTICALS INC (ANIP)
Cook Meredith — SR. VP, GENERAL COUNSEL & SEC.
Shares
500
Price
$78.16
Total Value
$39.08K
Shares Held After
78,390
% of Holdings
0.6%
Showing 1–50 of 329 transactions (page 1 of 7)